申请人:Wyeth
公开号:US06465482B2
公开(公告)日:2002-10-15
Compounds are provided which are useful for the treatment of serotonin-affected neurological disorders which comprise
Wherein:
R1, R2 and R3 are each, independently, hydrogen, halogen, CF3, alkyl, alkoxy, MeSO2, or together can form a 5-7 membered carbocyclic or heterocyclic ring;
R4 is hydrogen, halogen, or alkyl;
R5 is hydrogen, alkyl, alkylaryl, or aryl;
R6 is hydrogen, halogen, CF3, CN, carbamide, or alkoxy;
X1, X2 and X3 are each carbon or one of X1, X2 or X3 may be nitrogen;
Y is carbon or nitrogen; and
Z is carbon or nitrogen; or
pharmaceutically acceptable salts thereof.
提供了一些化合物,可用于治疗受血清素影响的神经系统疾病,其中:R1、R2和R3各自独立地为氢、卤素、CF3、烷基、烷氧基、MeSO2,或者一起形成一个5-7成员的碳环或杂环;R4为氢、卤素或烷基;R5为氢、烷基、烷基芳基或芳基;R6为氢、卤素、CF3、CN、尿素或烷氧基;X1、X2和X3各自为碳或其中一个可以是氮;Y为碳或氮;Z为碳或氮;或其药物可接受的盐。